Morgan Stanley
TLOG

Morgan Stanley’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Morgan Stanley’s Portfolio TLOG Stock Details TLOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-42,845
Closed -$6K – 6682
2016
Q3 		$6K Sell
42,845
-4,407
-9% -$1.02K ﹤0.01% 6220
2016
Q2 		$15K Sell
47,252
-44
-0.1% -$12 ﹤0.01% 5954
2016
Q1 		$9K Sell
47,296
-26,546
-36% -$7.37K ﹤0.01% 6168
2015
Q4 		$128K Buy
73,842
+1,238
+2% +$2.18K ﹤0.01% 5287
2015
Q3 		$134K Buy
72,604
+6,020
+9% +$14.3K ﹤0.01% 5288
2015
Q2 		$156K Buy
66,584
+14,231
+27% +$43.9K ﹤0.01% 5367
2015
Q1 		$229K Buy
52,353
+12,692
+32% +$63.7K ﹤0.01% 5135
2014
Q4 		$191K Sell
39,661
-14,852
-27% -$66.4K ﹤0.01% 5261
2014
Q3 		$227K Buy
54,513
+23,430
+75% +$109K ﹤0.01% 5075
2014
Q2 		$184K Buy
31,083
+2,315
+8% +$13.1K ﹤0.01% 5208
2014
Q1 		$184K Buy
28,768
+9,682
+51% +$87.3K ﹤0.01% 5158
2013
Q4 		$182K Buy
+19,086
New +$149K ﹤0.01% 5073

Other funds holding TLOG

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BWA
Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Morgan Stanley's TLOG Position: Q4 2016 in Review

Morgan Stanley sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 42,845 shares — an estimated $6K sold.

Morgan Stanley first reported a position in TLOG in Q4 2013 and held it in 12 quarters. The position peaked at $229K in Q1 2015. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

  • Morgan Stanley reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
  • Morgan Stanley sold 42,845 TetraLogic Pharmaceuticals Corporation shares in Q4 2016, an estimated $6K.
  • Morgan Stanley first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2013 and held it in 12 quarters.
  • Morgan Stanley's TetraLogic Pharmaceuticals Corporation position peaked at $229K in Q1 2015.
  • 3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on Morgan Stanley's 13F filing for Q4 2016, filed 13 Feb 2017.